Our observations support the view that BCL-XL works not only as essential cues for cell fate determination, but it also regulates pathways involved in the progression of melanoma and glioblastoma, as recently reported for pancreatic neuroendocrine and breast tumors5. Here, BCL2L1 is linked to glioblastoma.